Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CORVUS PHARMACEUTICALS, INC.

(CRVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société CORVUS PHARMACEUTICALS, INC.
11/12Corvus Pharmaceuticals Presents Updated Data from Mupadolimab (Anti-CD73) Phase 1/1b Cl..
GL
11/10Corvus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
GL
11/02Corvus Pharmaceuticals to Present Updated Mupadolimab (Anti-CD73) Data at 2021 Society ..
GL
11/02CORVUS PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Financial State..
AQ
11/01CORVUS : Q3 Earnings Snapshot
AQ
11/01Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2021 Financia..
PU
11/01CORVUS PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Conditi..
AQ
11/01Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2021 Financia..
GL
10/27Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval fo..
AQ
09/22Corvus Pharmaceuticals Provides Updates on Mupadolimab (Anti-CD73) Programs in Oncology..
GL
09/07Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
GL
08/17CORVUS PHARMACEUTICALS : Announces IND Acceptance for Phase 1/1b Clinical Trial of CPI-1 i..
AQ
08/16CORVUS PHARMACEUTICALS : Announces IND Acceptance for Phase 1/1b Clinical Trial of CPI-818..
AQ
08/03CORVUS PHARMACEUTICALS : Provides Business Update and Reports Second Quarter 2021 Financia..
AQ
08/03CORVUS PHARMACEUTICALS : Provides Business Update and Reports Second Quarter 2021 Financia..
PU
08/02CORVUS : Q2 Earnings Snapshot
AQ
08/02CORVUS PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and R..
AQ
08/02CORVUS PHARMACEUTICALS : Provides Business Update and Reports Second Quarter 2021 Financia..
AQ
07/15CORVUS PHARMACEUTICALS : Discontinues Phase 3 Study of Mupadolimab (Anti-CD73) for COVID-1..
PU
07/15CORVUS PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Other Events..
AQ
07/15CORVUS PHARMACEUTICALS : Discontinues Phase 3 Study of Mupadolimab (Anti-CD73) for COVID-1..
AQ
06/16CORVUS PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8..
AQ
05/25Corvus Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
GL
05/05Corvus Pharmaceuticals Completes Sale of $10 Million Through Its ATM Program
GL
04/30CORVUS PHARMACEUTICALS : Provides Business Update and Reports First Quarter 2021 Financial..
AQ
04/29CORVUS : Q1 Earnings Snapshot
AQ
03/25CORVUS PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and R..
AQ
03/25CORVUS : Q4 Earnings Snapshot
AQ
03/25CORVUS PHARMACEUTICALS : Provides Business Update and Reports Fourth Quarter and Full Year..
AQ
03/22CORVUS PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
03/05Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
GL
02/17CORVUS PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02/17Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock
GL
02/15CORVUS PHARMACEUTICALS : Announces Pricing of Public Offering of Common Stock
AQ
02/12Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
GL
02/11CORVUS PHARMACEUTICALS, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
02/11Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock
GL
02/04CORVUS PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
02/04Corvus Pharmaceuticals Initiates Phase 3 Clinical Trial of CPI-006 for Patients with CO..
GL
2020CORVUS PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2020CORVUS PHARMACEUTICALS : Presents New Data on its Investigational ITK Inhibitor CPI-818 at..
AQ
2020CORVUS PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
2020Corvus Presents New Data on its Investigational ITK Inhibitor CPI-818 at the American S..
GL
2020CORVUS PHARMACEUTICALS : Announces Upcoming CPI-818 Data Presentations at the American Soc..
AQ
2020Corvus Announces Upcoming CPI-818 Data Presentations at the American Society of Hematol..
GL
2020CORVUS PHARMACEUTICALS : Hosting R&D Symposium on November 12 to Highlight COVID-19 Progra..
AQ
2020Corvus Hosting R&D Symposium on November 12 to Highlight COVID-19 Program and Updated S..
GL
2020CORVUS PHARMACEUTICALS : Completes Enrollment in Phase 1 Study of CPI-006 for Patients wit..
AQ
2020CORVUS PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
2020CORVUS PHARMACEUTICALS : Completes Enrollment in Phase 1 Study of CPI-006 for Patients wit..
AQ
2020Corvus Completes Enrollment in Phase 1 Study of CPI-006 for Patients with COVID-19 and ..
GL
2020CORVUS PHARMACEUTICALS : COVID-19 Abstract Selected for 'Hot Topic' Oral Session at the 20..
AQ
2020CORVUS PHARMACEUTICALS : COVID-19 Abstract Selected for “Hot Topic” Oral Sessi..
AQ
2020Corvus Pharmaceuticals COVID-19 Abstract Selected for “Hot Topic” Oral Sess..
GL
2020CORVUS : 3Q Earnings Snapshot
AQ
2020CORVUS PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and R..
AQ
2020CORVUS PHARMACEUTICALS : Provides Business Update and Reports Third Quarter 2020 Financial..
AQ
2020Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2020 Financia..
GL
2020CORVUS PHARMACEUTICALS : to Present Updated Data from its Clinical Trial of CPI-006 for Pa..
AQ
2020Corvus Pharmaceuticals to Present Updated Data from its Clinical Trial of CPI-006 for P..
GL
2020CORVUS PHARMACEUTICALS : New Data from Corvus Phase 1 Study of CPI-006 Continues to Suppor..
AQ
2020CORVUS PHARMACEUTICALS : Announces Co-Founding of Angel Pharmaceuticals in China
AQ
2020CORVUS PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Completion of A..
AQ
2020CORVUS PHARMACEUTICALS : Announces Co-Founding of Angel Pharmaceuticals in China
AQ
2020Corvus Pharmaceuticals Announces Co-Founding of Angel Pharmaceuticals in China
GL
2020CORVUS PHARMACEUTICALS : New Data from Corvus Phase 1 Study of CPI-006 Continues to Suppor..
AQ
2020New Data from Corvus Phase 1 Study of CPI-006 Continues to Support its Potential as a T..
GL
2020CORVUS PHARMACEUTICALS : New Data from Ciforadenant Phase 1b/2 Clinical Study Presented at..
AQ
2020CORVUS PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
2020CORVUS PHARMACEUTICALS : New Data from Ciforadenant Phase 1b/2 Clinical Study Presented at..
AQ
2020New Data from Ciforadenant Phase 1b/2 Clinical Study Presented at ESMO Virtual Congress..
GL
2020CORVUS PHARMACEUTICALS : Appoints Edith Mitchell, M.D., to Board of Directors
AQ
2020CORVUS PHARMACEUTICALS : Provides Update on Clinical Trial of CPI-006 for Patients with CO..
AQ
2020CORVUS PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2020CORVUS PHARMACEUTICALS : Appoints Edith Mitchell, M.D., to Board of Directors
AQ
1  2  3Next
Upcoming event on CORVUS PHARMACEUTICALS, INC.
03/10/22